Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alberts

Showing results (131-140 of 205) with videos related to

Pageof 21
Sort By:
Stroke|February 14, 2014
Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke AssociationGregg C Fonarow, Mark J Alberts, Joseph P Broderick, et al.
Annals of Neurology|May 1, 1997
Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhageM J Alberts, J P Davis, C Graffagnino, et al.
Stroke|February 9, 2022
Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke: A Scientific Statement From the American Heart AssociationAmre Nouh, Sepideh Amin-Hanjani, Karen L Furie, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 16, 2020
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission DatabaseBenjamin Miao, Monique Miller, Belinda Lovelace, et al.
The American Journal of Cardiology|July 25, 2008
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelinesMichael H Davidson, Marshall A Corson, Mark J Alberts, et al.
Plos One|December 18, 2018
Hepatitis E virus seroprevalence and determinants in various study populations in the NetherlandsC J Alberts, M F Schim van der Loeff, S Sadik, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Helicobacter|March 10, 2020
Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS studyCatharina J Alberts, Rima Jeske, Catherine de Martel, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2019
Physiologically-Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid-to-Lactone ConversionBridget L Morse, Jeffrey J Alberts, Maria M Posada, et al.
Annals of Neurology|July 1, 1992
Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeG J del Zoppo, K Poeck, M S Pessin, et al.
Pageof 21

Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Stroke|February 14, 2014
Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke AssociationGregg C Fonarow, Mark J Alberts, Joseph P Broderick, et al.
Annals of Neurology|May 1, 1997
Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhageM J Alberts, J P Davis, C Graffagnino, et al.
Stroke|February 9, 2022
Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke: A Scientific Statement From the American Heart AssociationAmre Nouh, Sepideh Amin-Hanjani, Karen L Furie, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 16, 2020
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission DatabaseBenjamin Miao, Monique Miller, Belinda Lovelace, et al.
The American Journal of Cardiology|July 25, 2008
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelinesMichael H Davidson, Marshall A Corson, Mark J Alberts, et al.
Plos One|December 18, 2018
Hepatitis E virus seroprevalence and determinants in various study populations in the NetherlandsC J Alberts, M F Schim van der Loeff, S Sadik, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Helicobacter|March 10, 2020
Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS studyCatharina J Alberts, Rima Jeske, Catherine de Martel, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2019
Physiologically-Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid-to-Lactone ConversionBridget L Morse, Jeffrey J Alberts, Maria M Posada, et al.
Annals of Neurology|July 1, 1992
Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeG J del Zoppo, K Poeck, M S Pessin, et al.
Pageof 21